Show simple item record

FieldValueLanguage
dc.contributor.authorLeung, Sharon SY
dc.contributor.authorParumasivam, Thaigarajan
dc.contributor.authorGao, Fiona G
dc.contributor.authorCarrigy, Nicholas B
dc.contributor.authorVehring, Reinhard
dc.contributor.authorFinlay, Warren H
dc.contributor.authorMorales, Sandra
dc.contributor.authorBritton, Warwick J
dc.contributor.authorKutter, Elizabeth
dc.contributor.authorChan, Hak-Kim
dc.date.accessioned2019-05-17
dc.date.available2019-05-17
dc.date.issued2017-04-15
dc.identifier.urihttp://hdl.handle.net/2123/20424
dc.description.abstractThis study aimed to develop inhalable powders containing phages active against antibiotic-resistant Pseudomonas aeruginosa for pulmonary delivery. A Pseudomonas phage, PEV2, was spray dried into powder matrices comprising of trehalose (0–80%), mannitol (0–80%) and L-leucine (20%). The resulting powders were stored at various relative humidity (RH) conditions (0, 22 and 60% RH) at 4 ºC. The phage stability and in vitro aerosol performance of the phage powders were examined at the time of production and after 1, 3 and 12 months storage. After spray drying, a total of 1.3 log titer reduction in phage was observed in the formulations containing 40%, 60% and 80% trehalose, whereas 2.4 and 5.1 log reductions were noted in the formulations containing 20% and no trehalose, respectively. No further reduction in titer occurred for powders stored at 0 and 22% RH even after 12 months, except the formulation containing no trehalose. The 60% RH storage condition had a destructive effect such that no viable phages were detected after 3 and 12 months. When aerosolised, the total lung doses for formulations containing 40%, 60% and 80% trehalose were similar (in the order of 105 pfu). The results demonstrated that spray drying is a suitable method to produce stable phage powders for pulmonary delivery. A powder matrix containing ≥ 40% trehalose provided good phage preservation and aerosol performances after storage at 0 and 22 % RH at 4 ºC for 12 months.en_AU
dc.description.sponsorshipThis work was financially supported by the Australian Research Council (Discovery Project DP150103953). Authors are grateful to Tony Smithyman of Special Phage Services for his valuable discussion and advice. SSY Leung is a research fellow supported by the University of Sydney. T Parumasivam is a recipient of the Malaysian Government Scholarship. H-K Chan is funded by the National Institutes of Health (NIH Project no.1R21AI121627-01) and WJ Britton by the National Health and Medical Research Council Centre of Research Excellence in Tuberculosis Control (APP1043225).en_AU
dc.language.isoen_AUen_AU
dc.publisherElsevieren_AU
dc.relationARC DP150103953, NIH Project no.1R21AI121627-01, NHMRC APP1043225, University of Sydney Research Fellowship, Malaysian Government Scholarshipen_AU
dc.subjectPhageen_AU
dc.subjectPEV2en_AU
dc.subjectpulmonary infectionen_AU
dc.subjectmulti-drug resistanceen_AU
dc.subjectspray dryingen_AU
dc.subjectMDRen_AU
dc.titleEffects of storage conditions on the stability of spray dried, inhalable bacteriophage powdersen_AU
dc.typeArticleen_AU
dc.subject.asrcFoR::110203 - Respiratory Diseasesen_AU
dc.subject.asrcFoR::110309 - Infectious Diseasesen_AU
dc.subject.asrcFoR::111504 - Pharmaceutical Sciencesen_AU
dc.identifier.doihttps://doi.org/10.1016/j.ijpharm.2017.01.060
dc.type.pubtypePre-printen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.